Gulf Pharm Ind (JULPHAR)

Abu Dhabi
Currency in AED
1.280
-0.030(-2.29%)
Closed·
JULPHAR Scorecard
Full Analysis
High shareholder yield
Earnings results expected in 14 days
Fair Value
Day's Range
1.2801.330
52 wk Range
0.8031.780
Key Statistics
Edit
Bid/Ask
1.40 / 1.42
Prev. Close
1.33
Open
1.33
Day's Range
1.28-1.33
52 wk Range
0.803-1.78
Volume
1.32M
Average Volume (3m)
2.38M
1-Year Change
33.33%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
JULPHAR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1.420
Upside
+10.94%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth
Show more

Gulf Pharm Ind Company Profile

Gulf Pharmaceutical Industries P.S.C., together with its subsidiaries, manufactures and sells medicines, drugs, and various other types of pharmaceutical, cosmetic, and medical compounds in United Arab Emirates, other GCC countries, and internationally. It operates through Manufacturing, Planet, Investments, and Others segment. The company offers generic medicines for pain and inflammation, antiviral, respiratory, anti-infectives, immunosuppressants and selective immunosuppressants, cardio care, CNS and psychiatry, vitamins and supplements, wound care management, dermatology, endocrine, gynecology and women care, anemia, antibiotics, decongestants and other nasal preparations, hyperkalemia and hyperphosphatemia, urinary antispasmodics, erectile dysfunction, benign prostatic hyperplasia, and gastrointestinal tract. It also provides solutions for type 1, type 2, and gestational diabetes, such as insulin formulations of recombinant human insulin and continuous glucose monitoring systems. In addition, the company is involved in the transportation activities; general trading; distribution, wholesale, and retail trading of medicines and cosmetic products; facilities management services, health treatment undertaking services, and hospitals management; investment in commercial, industrial, and healthcare enterprises; and trading in medical equipment. Gulf Pharmaceutical Industries P.S.C. was incorporated in 1980 and is headquartered in Ras al-Khaimah, the United Arab Emirates.

Employees
2400

Compare JULPHAR to Peers and Sector

Metrics to compare
JULPHAR
Peers
Sector
Relationship
P/E Ratio
102.9x−0.1x−0.5x
PEG Ratio
0.69−0.100.00
Price/Book
1.9x2.0x2.6x
Price / LTM Sales
1.2x1.7x2.9x
Upside (Analyst Target)
10.9%110.2%64.0%
Fair Value Upside
Unlock16.0%9.4%Unlock

Analyst Ratings

0 Buy
0 Hold
1 Sell
Ratings:
1 analysts
Overall Consensus
Sell

Analysts 12-Month Price Target:

Average 1.420
(+10.94% Upside)

Earnings

Latest Release
Mar 24, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Gulf Pharm Ind (JULPHAR) Stock Price Today?

The Gulf Pharm Ind stock price today is 1.28

What Stock Exchange Does Gulf Pharm Ind Trade On?

Gulf Pharm Ind is listed and trades on the Abu Dhabi stock exchange.

What Is the Stock Symbol for Gulf Pharm Ind?

The stock symbol for Gulf Pharm Ind is "JULPHAR."

What Is the Gulf Pharm Ind Market Cap?

As of today, Gulf Pharm Ind market cap is 1.47B.

What is Gulf Pharm Ind Earnings Per Share?

The Gulf Pharm Ind EPS is 0.01.

What Is the Next Gulf Pharm Ind Earnings Date?

Gulf Pharm Ind will release its next earnings report on 06 May 2025.

From a Technical Analysis Perspective, Is JULPHAR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.